Search

everythinglearnresearchcommunity

for

Search:↓

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Finasteride increases P-glycoprotein activity in the liver and kidney.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Indinavir can cause hair loss and other skin problems.

Finasteride doesn't affect erections much, but may decrease libido in men.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Losartan can cause temporary loss of taste.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Finasteride reduces bleeding risk during prostate surgery.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Finasteride interacts with terazosin, but not doxazosin; caution needed.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Mesotherapy with dutasteride effectively treats hair loss with manageable side effects.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride improves chronic pelvic pain, saw palmetto doesn't.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.